Bioequivalence and Bioavailability Forum

Dear All

I would like to perform a BE study for a drug indicated to:

1. Prevention of endometrial hyperplasia in nonhysterectomized postmenopausal women who are receiving conjugated estrogens tablets.
   
2. Also indicated for use in secondary amenorrhea.

In this case should I recruit females with postmenopausal condition or no restriction should be done?

Thanks for your reply.

Regards